ACRV vs CVS · $65.1M cap vs P/E 16, rev $106.10B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
ACRV does not have a complete income-statement cache yet.
Latest reported CVS revenue for 2026-06-30 was $106.10B. Net income was $2.98B. Revenue was up 5.6% from 2026-03-31 to 2026-06-30. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
ACRV currently screens at market cap $65.1M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the ACRV and CVS stock pages for the full models.
Not investment advice.